Business Description
Histogen Inc
NAICS : 541714
SIC : 2833
ISIN : US43358Y2028
Description
Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 2.17 | |||||
| 9-Day RSI | 5.33 | |||||
| 14-Day RSI | 9.69 | |||||
| 6-1 Month Momentum % | 76.47 | |||||
| 12-1 Month Momentum % | -10.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -53026.32 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | 0.36 | |||||
| EV-to-EBITDA | 0.37 | |||||
| EV-to-Revenue | -236.21 | |||||
| EV-to-Forward-Revenue | 14.27 | |||||
| Earnings Yield (Greenblatt) % | 277.78 | |||||
| FCF Yield % | -11852.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HSTOQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Histogen Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.019 | ||
| EPS (TTM) ($) | -2.81 | ||
| Beta | 1.96 | ||
| Volatility % | 101.69 | ||
| 14-Day RSI | 9.69 | ||
| 14-Day ATR ($) | 0.012444 | ||
| 20-Day SMA ($) | 0.145853 | ||
| 12-1 Month Momentum % | -10.45 | ||
| 52-Week Range ($) | 0.02 - 0.55 | ||
| Shares Outstanding (Mil) | 4.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Histogen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Histogen Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Histogen Inc Frequently Asked Questions
What is Histogen Inc(HSTOQ)'s stock price today?
The current price of HSTOQ is $0.02. The 52 week high of HSTOQ is $0.55 and 52 week low is $0.02.
When is next earnings date of Histogen Inc(HSTOQ)?
The next earnings date of Histogen Inc(HSTOQ) is 2024-12-04 Est..
Does Histogen Inc(HSTOQ) pay dividends? If so, how much?
Histogen Inc(HSTOQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers